NeuBase Therapeutics Overview
NeuBase Therapeutics Discounted Cash Flow
DCF Analysis for NBSE.
Get informed when a big investor buys or sells
+ FollowFair Value
$2.97
Current Fair Value
$2.97
↑ 684.9% Upside
Undervalued by 684.9% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison